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Abstract
Background: The role of frozen section (FS) in intraoperative decision making for surgical staging of endometrial cancer is
controversial. Objective of this study is to assess the agreement rate between the FS and paraffin section (PS); and the
potential impact of the role of FS in the intra-operative decision making for the complete surgical staging in low risk
endometrial cancer.
Methods: This is a retrospective analysis of patients diagnosed with intra-operative FS stage I, grade I or II endometrial
cancer from 1995–2004. FS results were compared with final pathology results with regard to tumor grade, depth of
myometrial invasion, cervical involvement, lymphovascular invasion, and lymph node involvement. Agreement statistic with
kappa was calculated using SPSS statistical software. Categorical variables were tested using chi-square test with p value of
#0.05 being statistically significant.
Results: Of the 457 patients with endometrial cancer, 146 were evaluated by intra-operative FS and met inclusion criteria. FS
results were in disagreement with permanent section in 35% for the grade (kappa 0.58, p=0.003), 28% for depth of
myometrial invasion (kappa 0.61, p,0.0001), 13% for cervical involvement (kappa 0.78, p=0.002), and 32% for
lymphovascular invasion (kappa 0.6, p=0.01). Permanent pathology upstaged 31.9% & 23.2% of FS stage IA, & IB specimen
respectively. Lymph node dissection was done in 56.8%. Lymph node metastasis was identified in 8.4%. Use of
intraoperative FS would have resulted in suboptimal surgical treatment in 13% stage IA and 6.6% of stage IB patients
respectively by foregoing lymphadenectomy.
Conclusion: A significant number of patients with low risk endometrial cancer by FS were upstaged and upgraded on final
pathology. Before placing absolute reliance on intraoperative FS to undertake complete surgical staging, the inherent
limitation of the same in predicting final stage and grade highlighted by our data need to be carefully considered.
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Introduction
Endometrial cancer is the most common gynecologic malig-
nancy in the United States, with an estimated 43,400 new cases
diagnosed and 8000 deaths annually [1]. Most patients (71%) have
disease confined to the uterus (FIGO stage I) [1] [2]. In 1988 the
International Federation of Gynecology and Obstetrics (FIGO)
replaced clinical staging with surgical staging system for endome-
trial cancer [2]. It is supported by several studies which indicate
that as many as 25% and 50% of patients with clinical stage I, or II
disease respectively had disease outside the uterus at the time of
comprehensive surgical staging [3].
Whereas there is general agreement about the necessity of
complete surgical staging for high risk endometrial cancer as the
risk of nodal metastasis is high [4]; the need for pelvic and
paraaortic lymphnode dissection with complete surgical staging for
the low risk endometrial cancer has been debated passionately. [5]
[6] [7,8]. The pendulum swings with some advocating only
hysterectomy and bilateral salpingooophorectomy without node
dissection for low risk endometrial cancer [9] while others
advocating comprehensive surgical staging for all patients with
low risk disease [10]. Still others take an intermediate path and
believe that only a small fraction of patients with low risk
endometrial cancer may benefit from routine and comprehensive
surgical staging including a lymphadenectomy and the rest may be
adequately managed by routine hysterectomy with bilateral
salpingooophorectomy [11]. The key question however, is how
best to identify these patients who have seemingly low risk
endometrial cancer but may need complete surgical staging
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9instead. One widely used approach to address this critical question
is the use of intraoperative frozen section (FS) in the decision
making process. Here, the surgeon completes a hysterectomy and
if the FS shows high risk features, such as high grade, deep
myometrial invasion, lymphovascular space invasion, adnexal or
cervical involvement; then a comprehensive surgical staging is
undertaken and vice versa. This approach is not without its pitfalls.
The intra-operative assessment of grade and myometrial invasion
is based on a limited sample and may not be in agreement with the
final pathology. In addition, obscuring frozen artifact and
interobserver variability of gross tumor evaluation would also
confound the intraoperative microscopic assessment. It is therefore
important to find the agreement rate of the FS with respect to its
prediction of the final pathology in the paradigm of the complete
surgical staging of the low risk endometrial cancer. The literature
on this issue so far is controversial with some suggesting FS to be
reliable [12] [13] whereas others refuting the same [14]. This
controversy was highlighted by a recent study by Soliman et. al.
where half of the physicians indicated that they do not use FS and
the rest indicated that they use FS in their practice to decide when
to perform lymphadenectomy in endometrial cancer [15].
Therefore further data is urgently needed to resolve the
controversy in defining the role of FS in surgical staging of low
risk endometrial cancer.
The primary aim of this study is to assess the agreement rate
between FS and paraffin section (PS) in determining the grade,
depth of myometrial invasion, cervical involvement and lympho-
vascular space involvement. The secondary aim is to assess the
impact of disagreement between the FS and PS on the FIGO stage
designation of patients with presumed stage I low-grade
endometrial cancer by FS.
Materials and Methods
Ethics statement
This study was approved by the institutional review board (IRB)
of the Wayne State University. No patient consent was required
because the data were analyzed anonymously in a deidentified
fashion and it was a retrospective study. The institutional review
board (IRB) of the Wayne State University specifically waived the
need for consent.
This is a retrospective review of endometrial cancer patients
treated at Wayne State University from 1995 to 2004. All the
patients had pre-operative diagnosis of low-grade endometrial
cancer by endometrial biopsy or curettage. Here, low grade refers
to FIGO grade I and II. FIGO staging used in the paper refers to
the FIGO 1988 system of surgical staging.
Primary treatment was exploratory laparotomy with total
abdominal hysterectomy and bilateral salpingooophorectomy.
The FS was then done on the specimen. If high-risk features
were present on the FS, decision was taken to perform lymphnode
dissection. Lymphadenectomy was also done on some low risk
cases, based on the treating physician’s discretion. The inclusion
criteria were: endometrial cancer limited to uterus by clinical
assessment & imaging studies, low grade histology by preoperative
endometrial biopsy or dilation and curettage, and low grade (grade
I & grade II) endometrial cancer by intra operative FS with none
or ,50% myometrial invasion. Exclusion criteria were: intra-
operative FS findings of grade III, lymphovascular space invasion
(LVSI), poor prognosis histologic type like carcinosarcoma, serous
papillary or clear cell cancer, patients with intra-operative FS that
showed more than 50% depth of myometrial invasion and cases
where extra uterine disease was identified during the surgery. Also
patients with synchronous primary ovarian tumors were excluded.
Intraoperative FS assessment: the specimen was sectioned
serially at 2–3 mm intervals, grossly examined and areas of
maximum macroscopic depth of invasion were obtained for intra-
operative assessment. Two sections were taken for FS analysis. For
assessment of cervical involvement, two sections were obtained
from the lower uterine segment and endocervical junction for FS
assessment. A median of 4 sections were examined for each
patient. The sections were reviewed by the on-call pathologist and
reported to the surgeon. The maximum time from receiving the
specimen to having the report was 20 minutes. All final pathology
reports were determined by a gynecologic pathologist. For the
study, the FS slides were also reviewed by a gynecologic
pathologist together with the lymph node specimens without
knowing the results of final pathology results. The agreement
between the PS and FS was assessed using the agreement statistic,
(kappa). Comparison between the categorical variables was
assessed using the chi square test. A ‘p’ value of #0.05 was
considered statistically significant. SPSS was the statistical software
used for the analysis (SPSS Inc, Chicago, Ill).
Results
A total of 457 cases of endometrial carcinoma were treated by
hysterectomy during this study period at our institution of which
177 cases were evaluated for tumor grade and depth of
myometrial invasion by intra-operative FS. At the time of FS
analysis, 18% (31/177) patients were found to have a high grade
(FIGO grade III) tumor or a poor prognosis histology type and
were hence excluded; leaving 146 patients for the final analysis.
The median age of the study cohort was 60 (range 24–88) years.
Of the entire study cohort (n=146), 73 (50%) were grade I, 45
(31%) were grade II and 28 (19%) remained ungraded on initial
FS. These ungraded cases are not included in table 1 and are
represented by (UG) in figure 1. Of the 73 cases with grade I
disease, the FS and PS were in agreement in 41 (56.2%) patients
but the final pathology grade was advanced to grade II in 32
(43.8%, table 1, figure 1). For grade II by FS, 36 (80%) were
correlated in the final pathology report, whereas 6 cases (13.3%)
were upgraded to grade III & three (6.7%) cases were downgraded
to grade I (table 1, figure 1). Concordance between frozen and
permanent section for assessment of grade was 65.3% (kappa 0.58,
95%CI 0.51–0.68).
Myometrial invasion was assessed in 146 patients. By FS, 47
were found to have no MI (FS stage 1A as no extrauterine disease
identified at FS or preoperatively). Of these 47, 32(68%) were in
agreement on PS (table 2) whereas the remaining 15(32%) had
varying degree of MI. On the other hand, 99 patients were
reported to have ,50% MI on FS (IFS stage 1B as no extrauterine
disease identified at FS or preoperatively). Of these, 73(74%) were
in agreement (64 with final stage 1B whereas 9 with final stage II –
table 2). Of the remaining 26(26%), 12 had no MI whereas 14
were found to have $50% MI. Concordance between frozen and
Table 1. Comparison of histologic grade in frozen and
permanent sections.
Frozen section Permanent section diagnosis
Grade 1
73
Grade 1
41(56.2%)
Grade 2
32(43.8%)
Grade 3
0
Grade 2
45
Grade 1
3(6.7%)
Grade 2
36(80%)
Grade 3
6(13.3)
doi:10.1371/journal.pone.0021912.t001
Frozen Section in Endometrial Cancer
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(105/126) 72% (kappa 0.61, 95%CI 0.53–0.69).
Regarding the stage of the disease, 47 cases evaluated by FS
were found to have stage IA disease of which 32 (68%) were in
agreement, 11(23.4%) were upstaged to IB, 1 (2.1%) upstaged to
IIA and 3(6.4%) upstaged to IIIC. On the other hand, 99 patients
were thought to have stage IB disease by FS of which 64(64.6%)
were in agreement, 12 (12.1%) down staged to IA, 7 (7%) upstaged
to IC, 9 (9%) upstaged to II A & B (7% & 2% respectively), 3 (3%)
upstaged to IIIA, and 4 (4%) upstaged to stage IIIC (table 2,
figure 2). The FS displayed no cervical involvement for 122
patients in the study cohort of which 16 (13%) were determined to
be false negative by the permanent histology by virtue of
identification of tumor involving the cervix. Concordance between
frozen and permanent section for assessment of cervical invasion
was 86.9% (kappa 0.78, 95%CI 0.65–0.91) The FS stage in these
16 patients was FIGO IA in 3 and FIGO IB in 13. By definition of
the inclusion criteria, all patients were negative for LVSI by FS.
However, on final pathology report, 34 (31.7%) patients had
LVSI, 73 did not have LVSI and in the rest 39, it was not assessed.
It is noteworthy that 4 (14.2%) of patients with stage IA, and 30
(37.9%) of stage IB by FS, had positive LVSI. Concordance
between frozen and permanent section for assessment of LVSI was
68.3% (kappa 0.60, 95%CI 0.52–0.69).
A total of 83 of 146 (56.8%) patients underwent lymph node
dissection. Of these patients, 97.6% underwent pelvic while 42.1%
underwent paraaortic lymph node dissection. The median number
of pelvic nodes obtained was 7 (range 1–35) and that of paraaortic
lymph nodes was 4 (range 1–14). In all, 7 (8.4%) had lymph node
metastasis. Pelvic lymph node metastasis was found in 5 patients
(6%), whereas aortic lymph node metastasis was found in 1 (1.2%).
One patient had involvement of both, pelvic and paraaortic nodes
(1.2%). Of the 47 patients who had FS stage IA disease,
lymphadenectomy was done in 23 (48.9%) while 24 patients did
not have complete surgical staging. Of those who underwent
lymphadenectomy, 3 (13%) cases had positive lymph nodes and
were upstaged from IA to IIIC. All of these 3 cases had a change in
myometrial invasion from none to a median of 22% (18%, 22%
and 32% individually). In addition, they also had a change of FS
grade 2 to PS grade 3. Of the 99 patients with FS stage IB disease,
60(60.6%) patients had lymphadenectomy and 39 cases did not. A
total of 6.7%(n=4/60) patients in this subgroup had positive
nodes and were upstaged to FIGO Stage IIIC (figure 3). The
median myometrial invasion for these 4 patients was 58%. The
overall rate of agreement between the FS and that of the PS for
variables in question (grade, myometrial invasion, lymphovascular
space invasion and cervical invasion) is presented in table 3 along
with the agreement statistic; kappa.
Discussion
The management of low risk endometrial cancer has been a
subject of great controversy in our times. Central to the
controversy remain the independent yet intertwined issues of
lymphadenectomy and postoperative radiation therapy. Unfortu-
nately, rather than forging ahead with a unified theory of
treatment of this disease, there has been an emerging dichotomy
between the European and the North American way of
management of low risk endometrial cancer. The European
Figure 1. Relationship of tumor grade in frozen section to that of final pathology.
doi:10.1371/journal.pone.0021912.g001
Table 2. Comparison of stage in frozen and permanent
sections.
Frozen
section
stage Permanent section stage
IA
47
IA
32(68%)
IB
11(23.4%)
IC
0
IIA
1(2.1%)
IIB
0
IIIA
0
IIIC
3(6.3%)
IB
99
IA
12(12%)
IB
64(64.6%)
IC
7(7%)
IIA
7(7%)
IIB
2(2%)
IIIA
3(3%)
IIIC
4(4%)
doi:10.1371/journal.pone.0021912.t002
Frozen Section in Endometrial Cancer
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performing a total abdominal hysterectomy and bilateral salpin-
gooophorectomy without dissection of lymphnodes routinely. This
approach had been demonstrated by several prominent treatment
centers participating in some of the largest prospective randomized
control trial programs in endometrial cancer [9,16]. The
advocates of this approach cite a perceived lack of benefit from
routine lymphadenectomy in low risk endometrial cancer [5] [6]
along with achieving a potential benefit by sterilizing the nodal
harbors of residual neoplastic clones in the lymphatic basins by
aggressive use of adjuvant radiation [16]. In contrast is the North
American approach advocating a routine lymph node assessment
in endometrial cancer demonstrated by large cooperative group
trial programs [10] and suggested by the American College of
Obstetrics and Gynecology [17]. Supporters of this approach
believe that surgical removal of lymphatic basins reduces tumor
burden and minimizes the blanket use of unnecessary radiation,
which will be given more frequently if surgical removal of
lymphatic basins was not undertaken in this patient population.
The gnawing limitations emanating from inadequate lymph node
dissection and a lack of standard postoperative adjuvant treatment
has introduced serious flaws in the prospective randomized
lymphadenectomy trials [6] [5] and has further fuelled the
controversy surrounding the role of lymphadenectomy in low risk
endometrial cancer [18]. It has therefore become essential to
examine an approach suggested by many as a reasonable
compromise between the two polar opposite management
strategies, namely; selective lymphnode dissection in low risk
endometrial cancer based on high risk histology features
discovered during intraoperative FS. This approach is based on
the prerogative of maximizing pre-test probability of finding
lymphnode metastasis if formal lymphadenectomy was undertaken
and at least in theory, has the promise of avoiding the expense &
morbidity of lymphadenectomy in patients who are at extremely
low risk of lymphnode metastasis. On the other hand, it can also
reduce the prescription of unnecessary blanket postoperative
radiation. However, this intermediate approach of FS based
selective lymphadenectomy in low risk endometrial cancer relies
Figure 2. Relationship of FIGO stage in frozen section to that of final pathology.
doi:10.1371/journal.pone.0021912.g002
Figure 3. Lymphnode metastasis in frozen section FIGO stage
IA & 1B.
doi:10.1371/journal.pone.0021912.g003
Frozen Section in Endometrial Cancer
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(because the historic risk factors for lymphnode assessment are
based on final pathology rather than FS [4]) and the accuracy of
these variables in predicting the actual lymphatic metastasis. In the
present study, we evaluated the former of these two critical factors.
The first objective of this study was to correlate the grade and
depth of myometrial invasion by FS with that of permanent
pathology. Our results correlate with that of Frumovitz et al [14]
who showed that FS analysis of tumor grade and depth of
myometrial invasion are not always concordant with that of
permanent sections. In the present study, for the intra-operative
grade I, 44% were upgraded while in grade II, 13% were
upgraded and 6.6% were downgraded. Hence in our series, there
was 34.8% disagreement in assessing the grade of the tumor in
comparison with PS. The clinical significance of upgrading in
endometrial cancer was well depicted by Creasman et al. [4] in a
seminal GOG study showing that a change of grade from I to II
doubled the probability of middle third as well as outer third
myometrial invasion; both of which signify a higher recurrence
rate, poorer prognosis and generally call of additional adjuvant
radiation [16] [19]. Along the same lines, we observed that in
assessment of depth of myometrial invasion, disagreement was
found in 28% of the cases in comparison with the PS with the
overall agreement rate of 72%. More importantly, 7% of the cases
were upstaged from FIGO stage IB to IC; a subgroup of
endometrial cancer patients with extremely poor prognosis [20].
In this study, lymph node dissection was done in 56.8% of the
lesions evaluated by FS and positive lymphnodes were found in
8.4% of them overall. Our data display that 13% and 6.6%
patients in FS stage IA and IB respectively had lymphnode
metastasis. The seemingly paradoxical finding of a higher rate of
nodal metastasis in FS stage 1A in comparison to FS stage 1B can
be explained by the fact that the three patients who had the nodal
metastasis in FS stage 1A were all upgraded from grade 2 to grade
3 along with an amended extent of myometrial invasion from none
(on FS) to a median of 22% (on PS). These data display that if FS
was used in isolation for risk stratification; 7% to 13% patients
would have received suboptimal treatment by forgoing lymphad-
enectomy as they would have had positive nodes on lymphade-
nectomy. Although the statistical measure of agreement (kappa-
table 3) was generally in good/excellent range between the FS and
PS; a 7%–13% prevalence of missed nodal metastasis seems
clinically unacceptable for low risk endometrial cancer patients.
Therefore, the interpretation of kappa in this specific scenario
needs to be in context of the clinical implications rather than
independent of the later. The risk of pelvic lymphnode
involvement increases fivefold and that of paraaortic lymphnode
involvement increases six fold as the depth of myometiral invasion
changes from superficial to deep [4]. It is not unreasonable to
expect that in routine clinical practice, disagreement of FS in
prediction of grade, myometrial invasion and their cumulative
impact on reducing the prevalence of surgical assessment of
lymphnodes will be mutually multiplicative and has the potential
of leading to the suboptimal treatment in a substantial number of
patients. Similar to our study, others have reported a 5%–7% [12]
[13] risk of suboptimal surgical treatment of endometrial cancer
patients when FS analysis is considered as the basis of surgical
management. The overall agreement on LVSI between FS and PS
was 68.3%. The probability of finding LVSI on PS was higher for
FS stage 1B as compared to 1A (p=0.02, Chi square). This
observation will be consistent with the known risk stratification
value of LVSI where a presence of the same signifies a higher risk
category of endometrial cancer.
Selection of a section of endomyometrium for assessment of the
maximum depth of invasion is based on gross evaluation of the
tumor. This might prove to be difficult as often the findings could
be subtle especially when associated with a grade I tumor.
Furthermore, determination of the exact extent of myometrial
involvement in the setting of FS is challenging as the invasion line
can be extremely heterogeneous with presence of skip metastasis as
pointed out by others [12]. FS has poor sensitivity to detect
microscopic foci of the disease in the cervix, which could be found
only in permanent sections [21]. This was displayed in the present
study where the FS was 139% inaccurate on assessing the cervical
involvement by the tumor in comparison to the permanent
sections. The factors responsible for disagreement of FS grade
include inadequate sampling to assess the amount of solid growth
[22] and/or technical artifact associated with the surgery or FS
process which might hamper the assessment of nuclear atypia.
Evaluating additional sections would increase the agreement rate
between the FS and PS however it will delay the time to diagnosis
negating the advantage of this procedure [12]. Although we do not
have data in support, but it seems likely that the errors in FS may
be higher in absence of specialized gynecologic pathologists in
many community hospitals. This would indirectly imply that
where possible, referral to a gynecologic oncologist might be
considered at the initial diagnosis of endometrial cancer because
these physicians are specifically trained to perform accurate
surgical staging of endometrial cancer.
Although the therapeutic value of lymphadenectomy is
debatable in low risk endometrial cancer, the prognostic and
treatment planning implications are clear [23]. Therefore, the
consequences of errors that lead to incomplete surgical staging can
be substantial. Patients who are incompletely staged at the time of
the surgery and found to have high risk disease on final pathology,
may need extended field radiotherapy or further staging
procedures [24] [12]. The combination of surgery and radiother-
apy is associated with significant morbidity in up to 12% of the
patients [24]. Finally, the adverse financial impact of suboptimal
surgical staging has been shown by many as well [24,25,26].
The Limitation of this study is its retrospective nature combined
with limited number of patients. However the data was collected
Table 3. (%) Agreement between frozen section and paraffin section with the corresponding agreement statistic (Kappa) for
different variables in endometrial cancer.
Variable (%) Agreement Kappa (95% Confidence Interval for Kappa) p
Myometrial invasion 72 0.61 0.53–0.69 ,0.0001
Cervical invasion 86.9 0.78 0.65–0.91 0.002
Lymphovascular space invasion 68.3 0.60 0.52–0.69 0.01
Grade 65.3 0.58 0.51–0.68 0.003
doi:10.1371/journal.pone.0021912.t003
Frozen Section in Endometrial Cancer
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compared with the permanent sections by a gynecologic
pathologist who was blinded to the final outcome at the time of
assessment of the FS. Therefore, the bias in assessment of FS
histology was minimized. It is to be noted that the application of
the new FIGO 2009 staging criteria of the endometrial cancer to
our data may decrease the disagreement rate of the myometiral
invasion between FS and PS in terms of the upstaging. This is
because the new FIGO 2009 staging clubs together the older
(1988) stage IA and 1B. However, a large study of prospectively
maintained data at the Memorial Sloan Kettering Cancer Center,
New York [27], has highlighted the limitation of the new staging
schema as it eliminates the group of patients with the best
prognosis (i.e. old stage 1A=no myometrial invasion). It is also
correctly noted that the predictive value of the prognosis for the
new stage 1 system represents no improvements in comparison to
the older system. Therefore, our data is presented according to the
FIGO 1988 staging scheme.
In summary, our data displays that FS is poor indicator of
tumor grade and depth of myometrial invasion compared with
that of final permanent section report. Significant number of
patients with low-grade endometrial cancer based on intraoper-
ative FS will have a higher grade, a higher stage and presence of
lymphovascular space invasion on final pathology. Because a
substantial number of patients in our study underwent a
lymphnode dissection and were not identified to be at risk of
lymphnode metastasis by FS, we learned that the wisdom of basing
a decision of lymphadenectomy in endometrial cancer on the FS
may lead to suboptimal treatment of these patients. Hence, as
recommended by the American College of Obstetricians and
Gynecologists (ACOG) [17] we support the notion of complete
surgical staging along with lymphnode retrieval for patients with
low grade early stage endometrial cancer unless medical
contraindications exist.
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